Imaging for Adrenal Gland Issues using [18F]FNP-59
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 24 (estimated)
- Sponsor
- Benjamin Viglianti · Other
This trial is looking for people to help evaluate a new imaging technique for the adrenal gland. Some participants will be healthy individuals, while others will have known adrenal gland issues.
You may be able to join if
- I am a healthy person without known adrenal issues.
- I have abnormal adrenal hormone secretion.
You may not be able to join if
- I am pregnant.
- I cannot undergo imaging.
- I weigh more than 400 lbs.
- I am a prisoner.
- I cannot provide my own consent.
- I currently use steroids or certain hormone medications.
- I have known adrenal pathology.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis study will evaluate the feasibility of using a sub-therapeutic dose of a fluorine-18 analogue of NP-59 (\[18F\]FNP-59) to image the adrenal gland. Some participants are healthy normal subjects but have undergone interventions to manipulate hormones while other participants have known adrenal pathology.
Loading trial locations…